MARKET NEWS

Mateon Provides Update on Global Covid-19 Study
AIM ImmunoTech Announces First Healthy Subjects Dosed in Phase 1 Intranasal Ampligen Clinical Study
Ocuphire Announces Publication of MIRA-1 Phase 2b Results Demonstrating Reduction of Pharmacologically Induced Mydriasis
Aravive Announces First Patient Dosed in Phase 1b/2 Clinical Trial
twoXAR Pharmaceuticals Presents Preclinical Data Showing Significant Efficacy & Safety of Two Novel Chronic Kidney Disease Treatment Candidates
Codex DNA Releases World’s First Synthetic Genomes for Emerging SARS-CoV-2 Variants

  FEATURED EDITORIAL

  COMPANY PROFILE

Celanese works closely with you as a strategic partner to create innovative controlled-release dosage forms for biologics and small molecules to meet the goals of patient-centric therapies, improved medicine and better healthcare economics. Our scientists and engineers are there from concept to commercialization, providing development services, material supply aligned with GMP principles and regulatory support. Our objective is to help our customers reduce time and risk in research and development, so their drug achieves a higher chance of success. Our VitalDose Ethylene-Vinyl Acetate (EVA) copolymer drug-delivery platform is an enabling technology for drug-eluting implants, inserts and transdermal films. The platform is flexible and customizable to address a variety of formulation challenges when it comes to tailoring the release rate of your drug. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Vetter Establishes Office in China to Better Serve the Needs of its Growing Customer Base Worldwide

Vetter Establishes Office in China to Better Serve the Needs of its Growing Customer Base Worldwide

Vetter, one of the global leaders in prefilled drug-delivery systems, recently announced the opening of a new business entity in Shanghai, China…..

Baxter BioPharma Solutions & Moderna Announce Manufacturing Agreement for Covid-19 Vaccine in the US

Baxter BioPharma Solutions & Moderna Announce Manufacturing Agreement for Covid-19 Vaccine in the US

Baxter International Inc. and Moderna, Inc. recently announced they have entered into an agreement for Baxter BioPharma Solutions to provide fill/finish sterile manufacturing services and….

Metrics Contract Services Completes Russian Regulatory Inspection

Metrics Contract Services Completes Russian Regulatory Inspection

Metrics Contract Services recently announced its Greenville, NC, facility has successfully completed an inspection by the Ministry of Industry and Trade of the Russian Federation for commercial manufacture of….

Vectura Expands Dry Powder Inhaler Development & Manufacturing Capabilities 

Vectura Expands Dry Powder Inhaler Development & Manufacturing Capabilities 

Vectura Group plc, an industry leading inhalation CDMO, recently announced an expansion of its dry powder inhaler (DPI) development and manufacturing capabilities at its facility in Chippenham, UK…..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

March 24 – Parenteral Contract Manufacturing
March 31 – Polymers & Biomaterials